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IMPORTANCE The 2-year ophthalmic sequelae of Ebola virus disease (EVD) in survivors of
the 2013 to 2016 epidemic is unknown and may have public health implications for future
outbreaks.
OBJECTIVE To assess the potential for uveitis recurrence, the behavior of dark without
pressure, and visual outcomes in a cohort of Sierra Leonean survivors of EVD 2 years
following the 2013 to 2016 Ebola epidemic.
DESIGN, SETTING, AND PARTICIPANTS Prospective, 1-year observational cohort study
performed between 2016 and 2017 at 34 Military Hospital, Freetown, Sierra Leone.
Participants included survivors of EVD who reported ocular symptoms since Ebola treatment
unit discharge and were participants of a previous case-control study. Participants were
invited for ophthalmic reexamination and finger-prick blood sampling for immunoglobulin G
(IgG) to Toxoplasma gondii and HIV.
EXPOSURES Ebola virus disease.
MAIN OUTCOMES AND MEASURES Primary outcome measure: comparative ultra-widefield
retinal imaging. Secondary outcome measures: visual acuity and detection of IgG to T gondii
and HIV.
RESULTS Of 57 survivors of EVD who underwent repeated ophthalmic evaluation, 37 were
women (64.9%). Mean (SD) age was 31.9 (11.1) years. Median interval between first and last
examination was 370 days (interquartile range [IQR], 365-397.5 days), and median time from
discharge to last examination was 779 days (IQR, 732-821 days). Fifteen eyes of 10 survivors
(17.5%) had retinal lesions secondary to EVD. No new EVD-associated retinal lesions were
observed. Two survivors (3.5%) developed new posterior uveitis resembling toxoplasmosis
chorioretinitis and 41 (73%) were seropositive for T gondii IgG. Areas of dark without pressure
were observed either confined to the perimeter of Ebola retinal lesions (n = 7) and non-Ebola
lesions (n = 2), involving extensive retinal areas adjacent to Ebola retinal lesions (n = 4) and
non-Ebola lesions (n = 2) or in isolation (n = 6). Both expansion and regression of areas of
dark without pressure were observed over the study period. Best eye–presenting visual
acuity had mild or no visual impairment in 55 survivors (96.4%) 2 years following discharge.
CONCLUSIONS AND RELEVANCE Vision was maintained in survivors of EVD 2 years following
discharge. Evolving regions of dark without pressure may be associated with EVD retinal
lesions and might suggest the presence of an ongoing intraretinal stimulus, which may be
associated with infective etiology. Treatment strategies should account for the possibility
of toxoplasmosis chorioretinitis recurrence within survivors of EVD.
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E bola virus remains a serious public health threat. Re-search conducted following the aftermath of the 2013to 2016 West African Ebola virus disease (EVD) epi-
demic reported the prevalence of uveitis within survivors dur-
ing the convalescent period was between 13% and 34%.1-3 The
aqueous humor of 1 repatriated US survivor identified viable
Ebola virus during active uveitis 9 weeks after the clearance
of viremia.4
A retinal lesion specific to Ebola was identified in 15% of
previously symptomatic survivors.5,6 Lesions were predomi-
nantly nonpigmented, with a pale-gray appearance. Their
shapes are variable, but sharp angulations are characteristic.
Peripapillary lesions exhibited variable curvatures in keep-
ing with the retinal nerve fiber layer projections. Ocular co-
herence tomography (OCT) imaging demonstrates a charac-
teristic V-shaped hyperreflectivity of the outer nuclear layer
overlying discontinuities of the ellipsoid zone and interdigi-
tation zone in the smaller lesions, whereas larger lesions caused
a collapse of the retinal layers and loss of retinal thickness. Peri-
lesional areas of dark without pressure (DWP) (thinned ellip-
soid zone hyporeflectivity) accompanied 88.7% of lesions to
varying extents.
Relapses of uveitis in survivors of EVD up to 13 months af-
ter clearance of viremia have been reported (without aque-
ous etiological analysis),1 and the incidence of new uveitis at
1-year follow-up in a Liberian cohort of survivors with EVD was
significantly higher vs control individuals.7 However, there is
a high prevalence of uveitis secondary to other etiologies in
West Africa,8 and therefore recurrent ocular inflammation in
survivors of EVD may not necessarily be secondary to Ebola.9
This study aimed to investigate a cohort of survivors of EVD
who underwent detailed ophthalmic evaluation in early 20165
by undertaking reexaminations 1 year later to assess for evi-
dence of recurrent uveitis and changes in previously identi-
fied areas of DWP.6
Methods
Study Design and Population
A prospective, controlled study of survivors of EVD who had
attended the EVD survivors clinic at 34 Military Hospital in
Freetown, Sierra Leone, or other medical facilities in the re-
gion and reported ophthalmic symptoms since discharge was
conducted in 2016.5 All participants of this study who at-
tended between January 22, 2016, and April 26, 2016, were con-
tacted by telephone and invited to attend the ophthalmology
clinic for review 1 year following their baseline examination.
The study was approved by the Sierra Leone Ethics and Sci-
entific Review Committee and followed the tenets set forth by
the World Medical Association Declaration of Helsinki, sev-
enth revision (2013).
Ebola virus disease survivor status was verified by the
possession of a valid discharge certificate from an Ebola
treatment unit. Positive identification of survivors of EVD
at follow-up was confirmed by retinal vasculature morphol-
ogy comparison. Survivors were invited to participate in
English or Krio, as preferred, with local ophthalmic nurses
acting as interpreters. Consent was confirmed by fingerprint
or signature. Patients received treatment if required or were
referred on as needed at the discretion of the examining
ophthalmologist.
Data Collection
Ophthalmic examination and imaging were obtained on all sur-
vivors of EVD, consisting of presenting and pinhole visual acu-
ity (VA) (tumbling E-logMAR chart at 4 m); table-mounted
slitlamp examination; 2WIN autorefraction (Adaptica S.r.l);
color vision (14-plate Ishihara test book); icare TA01i re-
bound tonometry (Icare Oy); nonmydriatic, Daytona scan-
ning laser ophthalmoscope ultra-widefield imaging (Optos
PLC); and Topcon DRI Triton swept-source optical coherence
tomography (OCT) (Topcon Corporation). Image analysis is
described in eMethods 1 in the Supplement.
Blood Spot Analysis
Blood spots were obtained as described in eMethods 2 in the
Supplement. Blood spots (2 drops of approximately 80 μL per
spot) were collected on Whatman 903 Protein saver card (GE
Healthcare), passively dried at ambient room temperature
(typically 25°C to 30°C), exported, and then stored at −80°C
prior to analysis. Toxoplasma gondii immunoglobulin G (IgG)
status (TOXO IgG enzyme-linked immunosorbent assay;
DIAsource ImmunoAssays SA) and HIV-1 and HIV-2 status
(Murex HIV-1.2.O; DiaSorin S.p.A.) were determined from
the dried blood spot samples described in eMethods 3 in the
Supplement.
Main Outcome Measures
The primary outcome measure was change in retinal features
on ultra-widefield imaging. Secondary outcome measures in-
cluded visual impairment in survivors of EVD, surgical inter-
vention, reoccurrence of ocular inflammation and structural
complications, and detection of IgG to HIV and T gondii.
Statistical Analysis
Statistical analysis was performed with SPSS, version 22 (IBM).
Visual impairment was categorized using the World Health
Organization’s International Statistical Classification of Dis-
eases and Related Health Problems, Eleventh Revision (ICD-11)
6 grade classification.10
Key Points
Question What are the ophthalmic sequelae in survivors of the
2013 to 2016 Ebola epidemic?
Findings In this cohort study, no new Ebola retinal lesions were
observed and visual acuity was preserved at 2 years; however,
associated retinal dark without pressure did change with
regression and expansion of affected zones. New clinical
toxoplasmosis chorioretinal lesions occurred in 2 survivors.
Meaning Expanding dark without pressure might suggest an
ongoing intraretinal stimulus, which may be associated with
a viral infection; treatment strategies might take account of the
possibility of toxoplasmosis chorioretinitis recurrence within
survivors of Ebola.
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Results
Seventy-two survivors of EVD attended the 34 Military Hos-
pital Eye Clinic, Freetown, Sierra Leone, between January 22,
2016, and April 26, 2016. One year later, of the initial 72 sur-
vivors, 12 of the survivors’ contact telephone numbers were
either outside of the coverage zone or no longer available dur-
ing the follow-up period (minimum of 3 communication at-
tempts on different days). Sixty were contactable; 3 were un-
able to attend or declined the invitation; and 57 survivors
reattended for repeated ophthalmic examination. A total of 113
of 114 eyes were examined (1 prosthetic eye). Male-to-female
ratio of survivors of EVD was 1 to 1.85. Median age at the time
of ophthalmic examination was 30 years (interquartile range
[IQR], 25.5-39.5 years). Median time from Ebola treatment unit
discharge to baseline examination was 1.09 years (397 days;
IQR, 351-449.5 days).
Visual Acuity
Comparative VA outcomes between baseline and 1-year
follow-up examination are displayed in the eTable in the
Supplement.
Cataract Surgery
Three of 6 survivors of EVD diagnosed as having white cata-
racts (all unilateral) at baseline examination reattended for a
repeated examination. One had undergone manual small-
incision cataract surgery during the 1-year interim and im-
proved VA from light perception to 0.55 logMAR. Intraocular
pressure was 16 mm Hg in the operated eye. Early posterior
capsular opacification limited vision in addition to an epireti-
nal membrane and isolated foveal neurosensory retinal de-
tachment visible on OCT (eFigure 1 in the Supplement). A fur-
ther survivor with a right dense posterior subcapsular cataract
at baseline had also undergone manual small-incision cata-
ract surgery during the study period. Visual acuity improved
from hand movements to 0.7 logMAR. Fundus examination
demonstrated a peripheral pigmented retinal lesion with sur-
rounding hypopigmentation (eFigure 2 in the Supplement), not
in keeping with Ebola retinopathy, suggesting a possible al-
ternative etiology for cataract development.
Retinal Examination
Of the 57 patients recruited, 110 of 114 eyes were amenable to
retinal imaging at initial examination (no fundal view in 3 eyes
secondary to cataract; 1 prosthetic eye), and 109 eyes under-
went repeated imaging 1 year later (1 additional cataract lim-
ited retinal imaging). Fifteen eyes of survivors (13.6%) had reti-
nal lesions secondary to EVD as previously identified at the
initial examination,5 50% of which were bilateral.
Dark Without Pressure
Perilesional DWP (<1 disc diameter extent) was observed
around the circumference of EVD lesions in 7 eyes (6 survi-
vors) and pigmented chorioretinal lesions consistent with toxo-
plasmosis chorioretinitis lesions in 2 eyes (2 survivors). Sur-
vivors with extensive areas of DWP, their associated features,
and change during the observation period are summarized
in the Table (Figures 1, 2, 3, and 4; Video; eFigures 4-9 in
the Supplement). Areas of DWP were most frequently ob-
served in the nasal, midperipheral fundus (eFigure 3 in the
Supplement).
No intraocular inflammation was associated with areas of
DWP. No new retinal lesions in keeping with EVD were ob-
served in survivors with or without previously identified Ebola
retinal lesions during the follow-up period. New retinal le-
sions in keeping with toxoplasmosis chorioretinitis were ob-
served in 2 survivors of EVD during the follow-up period
(Figure 4) and were associated with mild vitritis.
Immunological Analysis
Sufficient blood spot samples were obtained from 56 of 57
survivors studied to enable an analysis of both T gondii IgG
and HIV IgG status. Forty-one survivors (73%) were positive
for T gondii IgG, and 1 (2%) was HIV IgG positive within
this cohort.
Discussion
We compared the ocular findings of a cohort of 57 Sierra Leo-
nean survivors of the 2014 to 2016 Ebola epidemic between
a year and 2 years following discharge. We did not find any
evidence of recurrent EVD retinal lesions during this period.
However, we provide widefield fundus imaging comparisons
to demonstrate active progression and regression of areas of
DWP, which was associated with transient perivascular infil-
trates in 1 survivor. Dark without pressure was present in
association with Ebola retinal lesions, with retinal lesions of
other etiology, and in isolation. We also report the occur-
rence of new clinical toxoplasmosis chorioretinitis in 2 survi-
vors of EVD within the period of observation, and the out-
comes of survivors who have undergone cataract surgery
during this time.
Dark Without Pressure
Isolated areas of homogeneous, geographical, flat, brown areas
of the fundi were first described as DWP in 1975 by Nagpal
et al.11 Unlike the name suggests, no association with or with-
out pressure/ocular indentation has been reported. Despite the
duration since its initial observation, DWP has attracted lim-
ited interest in the scientific literature and remains poorly
understood.6,12-15 There remains no histological correlation. We
previously demonstrated that DWP correlates to a thinned, hy-
poreflective second outer retinal band and a reflective loss of
the third hyperreflective band on OCT,6 termed the ellipsoid
zone (EZ) and interdigitation zone, respectively, by current
consensus.16 This led us to the hypothesis that DWP is caused
by a change in mitochondrial state. Cellular characterization
using immunohistochemistry markers17 concur with Spaide
and Curcio18 that the EZ is generated by the photoreceptor in-
ner segment ellipsoids, secondary to the tight bundles of
mitochondria18-22 as opposed to the inner segment/outer seg-
ment junction as previously termed.23,24 In vitro, the refrac-
tivity of isolated mitochondria is affected by their metabolic
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OD 0.00 20/20 121 75.7 −37 270° T S N
and 2 × Iso I
areas
Iso 0 PVI with accompanying
perivascular DWP extensions
noted at 22 mo (Figure 1);
simultaneous DWP expansion
and contraction at peripheral
margin; segmentation of
circumferential DWP (eFigure 4
in the Supplement); shifting
WWP
OS PL PL NAc NA NA NA NA NA White cataract, hypotony,
seclusio-pupillae and closed
angle. No fundal view (Video)
8 15.4
OD 0.00 20/20 60.3 79.1 25 90° N Enc EVD
lesions, 80°
I/MP
ExPL, Iso 3 Simultaneous DWP expansion
and contraction at N peripheral
margin; shifting WWP (Figure 2)
OS 0.00 20/20 NA NA NA NA NA 0 Shifting WWP
10 24.1
OD 0.1 20/25 NA NA NA DWP confined
to EVD lesion
margins
PL 4 Minimal change
OS 0.1 20/25 38.4 7.8 −80 180° N Enc
lesions/MP
ExPL 3 Predominant peripheral DWP
resolution, with scalloped edge
formation and segmentation of
circumferential DWP (Figure 3);
T WWP coalesce
17 13.6
OD 0.2 20/32 44.6 33.3 −25 S N Enc
lesions/MP,
FP
ExPL 0 Pigmented chorioretinal lesions.
New satellite lesion with mild
vitritis (Figure 4A and B)















I T pigmented chorioretinal
lesion
20 4
OD 0.06 20/25 6.4 13.6 113 Confined to
lesion margins
ExPL 0 Pigmented chorioretinal lesion
adjacent to the optic disc
(eFigure 5 in the Supplement)
OS 0.06 20/25 NAc NA NA NA NA 0 2 pigmented lesions <1/4 DD
24 14.3
OD 0.00 20/20 NAc NA NA NA NA 0 Normal fundus
OS 0.3 20/40 201.9 73.7 −26c 330° T N S/MP
FP
Iso 0 Circumferential DWP reduced
to 315° at 1 y and reduced DWP
peripheral extension
26 12.7
OD 0.1 20/25 NAc NA NA DWP confined
to non-Ebola
lesion margin
PL 0 ST FP pigmented chorioretinal
lesion
OS 0.12 20/25 9.7 17.8 84 56° N/MP Iso 0 Peripheral DWP expansion
(eFigure 6 in the Supplement)
34 13.7
OD 0.1 20/25 59.2 81.0 +37d MP ExPL 12 Extensive DWP, boundary ill
defined; DWP peripheral
expansion; WWP coalesce
OS 0.06 20/25 55.2 62 +12d MP ExPL 10 DWP peripheral expansion;
shifting WWP (eFigure 7 in the
Supplement)
38 15.1
OD 0.3 20/40 246 190.7 +18d 360° MP, FP Iso 0 Circumferential DWP expansion
(eFigure 8 in the Supplement)
OS 0.5 20/63 171.4 207.4 +21d 230° N I/MP,
FP
Iso 0 DWP expansion into beyond
visible retina on imaging
(eFigure 9 in the Supplement);
temporal WWP expansion
56 13.7
OD 0.06 20/25 1.86 0 −100 S 3 × Iso areas
MP, FP
Iso 0 DWP resolution at 1 y
OS 0.08 20/25 NAc NA NA NA NA 0 Normal fundus
Abbreviations: DD, disc diameter; DWP, dark without pressure; ETU, Ebola
treatment unit; EVD, Ebola virus disease; ExPL, extensive DWP encompassing
lesions; FP, FarPeriphery; I, inferior fundus; Iso, isolated (not associated with
other retinal lesions); MP, midperiphery; N, nasal fundus; NA, not applicable;
Pig, pigmented; PL, perilesional; PVI, perivascular infiltrates; S, superior fundus;
T, temporal fundus; VA, visual acuity; WWP, white without pressure.
a Presenting logMAR at 1-year follow-up examination.
b Area measured in optic disc areas.
c No DWP.
d DWP margins only partly defined. Calculated area represents comparable
defined DWP boundary. Area represents an underestimation of true DWP
extent.
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state.25,26 Although retinal functional assessment of areas of
DWP is limited, attenuation of the EZ on OCT is well recog-
nized as a detrimental sign of cell function and health,27
and the restoration of this band has been associated with re-
stored VA following retinal detachment surgery28 and macula
hole closure.29
Figure 1. Contralateral Retinal Imaging of a Survivor With Severe Ebola Related Uveitis





Optical coherence tomographyC Perivascular extension of dark without pressureD
A, Ultra-widefield fundus image of survivor 1’s right eye. B, Perivascular infiltrate. C, OCT demonstrating thinned, hyporeflective ellipsoid zone. D, Perivascular
infiltrate and extension of dark without pressure following the vascular distribution.
Figure 2. Simultaneous Expansion and Regression of Dark Without Pressure




Survivor 8’s right eye. Sequential ultra-widefield fundus image comparison demonstrating simultaneous expansion and regression of dark without pressure area.
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The sequential imaging in this study has provided new in-
sights into the behavior of these areas. Contraction and ex-
pansion of areas of DWP have been previously observed11,15;
however, Figure 2 and eFigure 3 in the Supplement provide
evidence that affected areas of DWP do not behave in a
unified manner, ie, equally expanding or contracting in uni-
son. Instead, while one border may advance to occupy fur-
ther retinal territory, neighboring borders can simultane-
ously retract.
Expansion of areas of DWP appears to occur contiguously
from the margin of existing areas. Similarly, resolution of areas
of DWP only occur from their peripheral margins and do so at
spatially uneven velocities, often leading to the formation of
scalloped edges (Figure 3) that can advance sufficiently through
Figure 3. Regression of Dark Without Pressure




Survivor 10’s left eye. Sequential ultra-widefield fundus image comparison demonstrating regression of dark without pressure. White arrowheads indicate Ebola
retinal lesions.
Figure 4. Recurrent and New Areas of Toxoplasmosis Chorioretinitis
Survivor 17, right eye, February 2016A
Survivor 47, left eye, February 2016C Survivor 47, left eye, March 2017D
Survivor 17, left eye, March 2017B
A and B, Survivor 17’s right eye (A and
B), sequential ultra-widefield fundus
image comparison in February 2016
(A) and March 2017 (B). White
arrowhead indicates site of new
retinal lesion in keeping with
surrounding lesions suggestive of
recurrent toxoplasmosis
chorioretinitis. C and D, Survivor 47’s
left eye, sequential ultra-widefield
fundus image comparison in February
2016 (C) and March 2017 (D). New
superior nasal retinal lesion visible in
image D is in keeping with
toxoplasmosis chorioretinitis and
adjacent Kyrieleis vasculitis.
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an area to create segmentation and isolated areas of DWP
(Figure 3; eFigure 3 in the Supplement).
Where areas of DWP appear spatially associated with Ebola
retinal lesions, regression appears to occur toward the retinal
lesion (Figure 3), leaving a persistent perilesional halo around
most lesions. This raises the possibility that where only per-
ilesional areas of DWP were identified at baseline imaging (a
year following Ebola treatment unit discharge), more exten-
sive areas of DWP may have been present at an earlier period
during convalescence.
No signs of intravitreal or retinal inflammation were ob-
served in survivors without new clinical toxoplasmosis cho-
rioretinitis, except for 1 survivor where multifocal perivascu-
lar infiltrates were observed. These were within areas of DWP
(with no visible Ebola retinal lesions), with fingerlike exten-
sions of DWP seen following the affected vessels at 22 weeks
following discharge (Figure 1A and D).
The presence of DWP around Ebola retinal lesions, which
retracts back toward Ebola retinal lesions while demonstrat-
ing ongoing fluctuations of expansion and contraction, strongly
suggests the presence of an ongoing intraretinal stimulus as-
sociated with the Ebola retinal lesion. Whether this repre-
sents ongoing intraretinal viral persistence remains specula-
tive, but reports of viral RNA persistence up to 40 months
following symptom onset in semen samples7 suggest it is theo-
retically plausible. Dark without pressure is not specific to
Ebola, so maybe a nonspecific response to infection or trig-
gered by infection. Dark without pressure is easier to discern
in pigmented fundi and is therefore perhaps more wide-
spread in white or lightly pigmented fundi than realized.
Cataracts
In our primary cohort (n = 82), white cataracts only occurred
unilaterally (n = 6) with normal VA in the contralateral eye.
There is increasing evidence to suggest cataract surgery can
be safely conducted in survivors of EVD.30 All reported reverse-
transcriptase polymerase chain reaction test results of aque-
ous fluid in survivors of EVD with recurrent uveitis31 or be-
fore cataract surgery5,30 have been negative for Ebola virus.
Cataract surgery performed on survivors of EVD within our co-
hort demonstrated VA improvements; however, early poste-
rior capsular opacification limited maximal visual benefit, and
in-country access to Nd:YAG laser facilities are very limited.
New retinal lesions indicative of toxoplasmosis chorioretini-
tis were visible on the fundus of 1 survivor within this cohort
following small-incision cataract surgery for posterior sub-
capsular cataracts. The seroprevalence of T gondii IgG was 73%
within our cohort, in keeping with uveitis secondary to T gon-
dii being common in West Africa.8 Retinal lesions suggestive
of toxoplasmosis chorioretinitis were also present in 18.2% and
19% of survivors of EVD and local control individuals, respec-
tively, in our previous study.5 Therefore, a differential diag-
nosis for cataracts within survivors of EVD must include al-
ternative etiologies that are common in the West African
population.
Evidence of Recurrence
Recurrent episodes of uveitis in survivors of EVD in Guinea
have been attributed to Ebola without polymerase chain
reaction corroboration.1 The detection of new retinal lesions
with the typical appearance of toxoplasmosis chorioretinitis
in 2 survivors (4%) of this cohort during a 1-year observation
period suggests any uveitis recurrence in survivors of EVD
in West Africa may be owing to an alternative etiology,
although further confirmatory serological or aqueous analy-
sis was not conducted in this study. Current World Health
Organization guidelines for the management of uveitis in
survivors of EVD suggest systemic corticosteroids (adults) or
methotrexate (children) if no resolution is seen within 7 days
of topical prednisolone.32 The high prevalence of toxoplas-
mosis within the region is recognized8 and within this
cohort was identified by serology, together with clinical evi-
dence suggestive of recurrent toxoplasmosis chorioretinitis.
When faced with episodes of recurrent, pan or posterior uve-
itis in survivors of EVD, clinicians should consider T gondii
chorioretinitis in the differential diagnosis. If T gondii cannot
be excluded, appropriate treatment should be included in
the treatment plan.
Limitations
Our study has limitations in part related to the setting, with
severely limited health care infrastructure. The prevalence of
DWP within the general population in West Africa is cur-
rently unknown. Our cohort was drawn from survivors of EVD
who previously reported ocular symptoms; therefore, gener-
alizations to the survivor population as a whole are uncer-
tain. Most patients were examined a year apart, so the occur-
rence of asymptomatic uveitis episodes or reversible changes
to lesions in the intervening time is unknown. Dimension cal-
culations of peripheral lesions on widefield imaging are sus-
ceptible to underestimation owing to peripheral warping in
projecting a 3-dimensional retina to a 2-dimensional image.
Conclusions
No new cases of recurrent uveitis secondary to Ebola were iden-
tified during the 1-year observation period within a cohort of
57 survivors, and VA was maintained. New chorioretinal le-
sions typical of T gondii chorioretinitis were identified. Dark
without pressure both enlarged and contracted. Although the
relevance of DWP is undetermined, our observations are con-
sistent with a retinal response to an infectious etiology pos-
sibly through mitochondrial change. Cataract secondary to EVD
uveitis was uncommon and unilateral. Cataract surgery ap-
pears to be safe and can enable visual gains.
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